Sigma Planning Corp Acquires Shares of 10,324 Clover Health Investments, Corp. (NASDAQ:CLOV)

Sigma Planning Corp bought a new position in Clover Health Investments, Corp. (NASDAQ:CLOV) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 10,324 shares of the company’s stock, valued at approximately $29,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. XTX Topco Ltd bought a new position in shares of Clover Health Investments in the second quarter worth about $932,000. AQR Capital Management LLC lifted its holdings in Clover Health Investments by 4.6% during the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after buying an additional 32,288 shares in the last quarter. Choreo LLC purchased a new stake in Clover Health Investments in the 2nd quarter valued at about $344,000. Bayesian Capital Management LP bought a new position in Clover Health Investments in the 1st quarter worth about $142,000. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Clover Health Investments during the second quarter worth approximately $203,000. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Trading Down 1.3 %

Shares of Clover Health Investments stock opened at $3.04 on Monday. The firm has a market cap of $1.52 billion, a P/E ratio of -15.20 and a beta of 2.03. Clover Health Investments, Corp. has a 12 month low of $0.61 and a 12 month high of $4.71. The stock’s fifty day moving average price is $3.52 and its 200-day moving average price is $2.28.

Clover Health Investments (NASDAQ:CLOV) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.03) by $0.01. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. The business had revenue of $330.99 million during the quarter, compared to analyst estimates of $347.60 million. During the same quarter in the previous year, the business posted ($0.09) EPS. Analysts forecast that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Analysts Set New Price Targets

Separately, UBS Group initiated coverage on Clover Health Investments in a research note on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective on the stock.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.